| __timestamp | Ligand Pharmaceuticals Incorporated | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12122000 | 18516000 |
| Thursday, January 1, 2015 | 13380000 | 34140000 |
| Friday, January 1, 2016 | 21221000 | 51872000 |
| Sunday, January 1, 2017 | 26887000 | 71772000 |
| Monday, January 1, 2018 | 27863000 | 97501000 |
| Tuesday, January 1, 2019 | 55908000 | 118590000 |
| Wednesday, January 1, 2020 | 59392000 | 169802000 |
| Friday, January 1, 2021 | 69012000 | 192507000 |
| Saturday, January 1, 2022 | 36082000 | 199563000 |
| Sunday, January 1, 2023 | 24537000 | 253598000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ligand Pharmaceuticals Incorporated and Xencor, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Xencor's R&D expenses surged by over 1,270%, peaking in 2023 with a staggering $254 million, reflecting its aggressive pursuit of new therapies. In contrast, Ligand Pharmaceuticals showed a more conservative approach, with a peak in 2021 at $69 million, before a notable decline to $24 million in 2023. This divergence highlights Xencor's robust focus on expanding its research capabilities, while Ligand may be optimizing its resources elsewhere. As the biotech landscape evolves, these strategic choices will undoubtedly shape their future trajectories.
Eli Lilly and Company or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Comparing Innovation Spending: Amgen Inc. and Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xencor, Inc.
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds
R&D Spending Showdown: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.
Comparing Innovation Spending: Ligand Pharmaceuticals Incorporated and Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.
R&D Spending Showdown: Evotec SE vs Xencor, Inc.